# Vivex Biologics, Inc. – FDA Inspection, Aug 4, 2022

Source: https://www.keypedia.com/records/fda_inspections/vivex-biologics-inc/5644a0b1-1058-4273-a185-3ba52a0d6334
Source feed: FDA_Inspections

> FDA inspection 1176417 of Vivex Biologics, Inc., August 04, 2022. Classification: Voluntary Action Indicated (VAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176417
- Company Name: Vivex Biologics, Inc.
- Inspection Date: 2022-08-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1226932 - 2024-01-12](https://www.keypedia.com/records/fda_inspections/vivex-biologics-inc/b424f1e1-385f-46b2-ac3e-d697db978d12)
- FDA Inspection 1067763 - 2018-09-21
- [FDA Inspection 1016973 - 2017-07-06](https://www.keypedia.com/records/fda_inspections/vivex-biologics-inc/e11ad27e-258b-4f79-8dee-db1709400c96)
- [FDA Inspection 951971 - 2015-12-18](https://www.keypedia.com/records/fda_inspections/vivex-biologics-inc/e5d9198b-0440-4bf0-8c70-585ea339c1a8)
- FDA Inspection 863049 - 2013-12-13

Company: https://www.keypedia.com/companies/vivex-biologics-inc/53889265-7ee0-41bd-964a-e596f7a588e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
